Taiwan has antimalarial drug seen as possible COVID-19 treatment: CECC
Taipei, March 26 (CNA) Quinoline antimalarial drugs, which have recently been discussed as a possible treatment for the COVID-19 coronavirus, are produced in Taiwan and could be made available if testing proves them to be effective, the Central Epidemic Command Center (CECC) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
U.S. to deliver 2.5 million doses of Moderna vaccine to Taiwan Sunday06/19/2021 10:47 PM
Clinic fined NT$4 million for vaccinating non-priority individuals06/19/2021 10:27 PM
COVID home test kits to go on sale in Taiwan next week: FDA06/19/2021 09:06 PM
Only 5 confirmed Delta variant cases found in Taiwan, all imported: CECC06/19/2021 08:55 PM
NTU to erect plaque to commemorate Chen Wen-chen's death06/19/2021 08:15 PM